相似文献
1
The role of stem cell transplantation for chronic myelogenous leukemia in the 21st century.
Blood. 2015 May 21;125(21):3230-5. doi: 10.1182/blood-2014-10-567784. Epub 2015 Apr 7.
2
Role of allo-SCT for CML in 2010.
Bone Marrow Transplant. 2010 Nov;45(11):1579-86. doi: 10.1038/bmt.2010.138. Epub 2010 Jun 7.
3
Transplant to treatment-free remission: the evolving view of 'cure' in chronic myeloid leukemia.
Expert Rev Hematol. 2015 Dec;8(6):785-97. doi: 10.1586/17474086.2015.1087843. Epub 2015 Sep 12.
4
Stem cell transplantation for chronic myeloid leukemia (CML): current indications and perspectives.
Curr Cancer Drug Targets. 2013 Sep;13(7):775-8. doi: 10.2174/15680096113136660094.
5
Allogeneic Stem Cell Transplantation for Patients with T315I BCR-ABL Mutated Chronic Myeloid Leukemia.
Biol Blood Marrow Transplant. 2016 Jun;22(6):1080-1086. doi: 10.1016/j.bbmt.2016.03.012. Epub 2016 Mar 16.
6
Outcomes of allogenic hematopoietic cell transplantation for childhood chronic myeloid leukemia: Single-center experience.
Pediatr Transplant. 2020 Jun;24(4):e13664. doi: 10.1111/petr.13664. Epub 2020 Feb 11.
7
Outcome of allogeneic SCT in patients with chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.
Ann Hematol. 2013 Apr;92(4):487-96. doi: 10.1007/s00277-012-1650-8. Epub 2012 Dec 19.
8
Chronic myeloid leukemia-transplantation in the tyrosine kinase era.
Hematol Oncol Clin North Am. 2014 Dec;28(6):1037-53. doi: 10.1016/j.hoc.2014.08.002. Epub 2014 Oct 5.
9
Outcomes Following Bone Marrow Transplantation in Children With Accelerated Phase or Blast Crisis Chronic Myelogenous Leukemia in the Era of Tyrosine Kinase Inhibitors.
J Pediatr Hematol Oncol. 2016 Nov;38(8):610-614. doi: 10.1097/MPH.0000000000000636.
10
Molecular monitoring of BCR-ABL transcripts after allogeneic stem cell transplantation for chronic myeloid leukemia.
Biol Blood Marrow Transplant. 2013 May;19(5):735-40. doi: 10.1016/j.bbmt.2013.01.007. Epub 2013 Jan 17.
引用本文的文献
1
Impact of First- and Second-Generation Tyrosine Kinase Inhibitors on the Development of Graft-Versus-Host Disease in Individuals with Chronic Myeloid Leukemia: A Retrospective Analysis on Behalf of the Polish Adult Leukemia Group.
Biomedicines. 2025 Jan 11;13(1):163. doi: 10.3390/biomedicines13010163.
2
[Research on the clinical characteristics and prognosis of children with chronic myeloid leukemia in the blast phase].
Zhonghua Xue Ye Xue Za Zhi. 2024 Oct 14;45(10):931-936. doi: 10.3760/cma.j.cn121090-20240130-00045.
3
An Update on the Management of Advanced Phase Chronic Myeloid Leukemia.
Curr Hematol Malig Rep. 2023 Dec;18(6):234-242. doi: 10.1007/s11899-023-00709-4. Epub 2023 Aug 31.
4
Anti-Cancer Effects of Oxygen-Atom-Modified Derivatives of Wasabi Components on Human Leukemia Cells.
Int J Mol Sci. 2023 Apr 6;24(7):6823. doi: 10.3390/ijms24076823.
5
Management of children and adolescents with chronic myeloid leukemia in blast phase: International pediatric CML expert panel recommendations.
Leukemia. 2023 Mar;37(3):505-517. doi: 10.1038/s41375-023-01822-2. Epub 2023 Jan 27.
6
A case of chronic myelogenous leukemia with the T315I mutation who progressed to myeloid blast phase and was successfully treated with asciminib.
Clin Case Rep. 2022 Nov 6;10(11):e6478. doi: 10.1002/ccr3.6478. eCollection 2022 Nov.
7
Defining Higher-Risk Chronic Myeloid Leukemia: Risk Scores, Genomic Landscape, and Prognostication.
Curr Hematol Malig Rep. 2022 Dec;17(6):171-180. doi: 10.1007/s11899-022-00668-2. Epub 2022 Aug 6.
8
Successful eradication of chronic myeloid leukemia in a child despite allogeneic graft rejection.
Cancer Rep (Hoboken). 2022 Oct;5(10):e1663. doi: 10.1002/cnr2.1663. Epub 2022 Jul 7.
9
Outcomes and toxicity of allogeneic hematopoietic cell transplantation in chronic myeloid leukemia patients previously treated with second-generation tyrosine kinase inhibitors: a prospective non-interventional study from the Chronic Malignancy Working Party of the EBMT.
Bone Marrow Transplant. 2022 Jan;57(1):23-30. doi: 10.1038/s41409-021-01472-x. Epub 2021 Oct 1.
10
Understanding and Monitoring Chronic Myeloid Leukemia Blast Crisis: How to Better Manage Patients.
Cancer Manag Res. 2021 Jun 23;13:4987-5000. doi: 10.2147/CMAR.S314343. eCollection 2021.
本文引用的文献
1
Impact of early molecular response in children with chronic myeloid leukemia treated in the French Glivec phase 4 study.
Blood. 2014 Oct 9;124(15):2408-10. doi: 10.1182/blood-2014-05-578567. Epub 2014 Aug 28.
2
Real-world cost-effectiveness in chronic myeloid leukemia: the price of success during four decades of development from non-targeted treatment to imatinib.
Leuk Lymphoma. 2015 May;56(5):1385-91. doi: 10.3109/10428194.2014.953141. Epub 2014 Oct 21.
3
An update on allogeneic hematopoietic progenitor cell transplantation for myeloproliferative neoplasms in the era of tyrosine kinase inhibitors.
Bone Marrow Transplant. 2014 Nov;49(11):1352-9. doi: 10.1038/bmt.2014.176. Epub 2014 Aug 4.
4
Managing children with chronic myeloid leukaemia (CML): recommendations for the management of CML in children and young people up to the age of 18 years.
Br J Haematol. 2014 Oct;167(1):33-47. doi: 10.1111/bjh.12977. Epub 2014 Jun 30.
5
Sensitivity of hematological malignancies to graft-versus-host effects: an EBMT megafile analysis.
Leukemia. 2014 Nov;28(11):2235-40. doi: 10.1038/leu.2014.145. Epub 2014 Apr 30.
6
Dipeptidylpeptidase IV (CD26) defines leukemic stem cells (LSC) in chronic myeloid leukemia.
Blood. 2014 Jun 19;123(25):3951-62. doi: 10.1182/blood-2013-10-536078. Epub 2014 Apr 28.
7
Chronic myeloid leukemia: 2014 update on diagnosis, monitoring, and management.
Am J Hematol. 2014 May;89(5):547-56. doi: 10.1002/ajh.23691.
8
Preclinical targeting of human acute myeloid leukemia and myeloablation using chimeric antigen receptor-modified T cells.
Blood. 2014 Apr 10;123(15):2343-54. doi: 10.1182/blood-2013-09-529537. Epub 2014 Mar 4.
9
Symptom distress predicts long-term health and well-being in allogeneic stem cell transplantation survivors.
Biol Blood Marrow Transplant. 2014 Mar;20(3):387-95. doi: 10.1016/j.bbmt.2013.12.001. Epub 2013 Dec 17.
10
Chronic Myelogenous Leukemia, Version 1.2014.
J Natl Compr Canc Netw. 2013 Nov;11(11):1327-40. doi: 10.6004/jnccn.2013.0157.
Zotero 插件